Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Repeat Dosing of Psilocybin in Headache Disorders


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04218539

Organisation Name: Yale University

Overal Status: Recruiting

Start Date: August 10, 2021

Last Update: October 25, 2021

Lead Sponsor: Yale University

Brief Summary: In seeking to understand the capacity for psilocybin to reduce migraine headache burden, this study will investigate single and repeated dosing of psilocybin up to two doses. In seeking to identify an underlying mechanism in psilocybin's effects, neuroinflammatory markers for migraine headache will be measured.

Conditions:
  • Migraine Headache


Total execution time in seconds: 0.18677091598511